The Safety and Efficacy of Adalimumab in Patients with Crohn's Disease: The Experience of a Single Tertiary Care Center

被引:0
|
作者
Teriaky, Anouar [1 ]
Mosli, Mahmoud [1 ]
Gregor, Jamie [1 ]
Yan, Brian [1 ]
Ponich, Terry [1 ]
Chande, Nilesh [1 ]
机构
[1] Univ Western Ontario, London, ON, Canada
来源
关键词
D O I
10.14309/00000434-201310001-01701
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
1701
引用
收藏
页码:S512 / S512
页数:1
相关论文
共 50 条
  • [1] The safety and efficacy of adalimumab in patients with Crohn's disease: the experience of a single Canadian tertiary care centre
    Teriaky, Anouar
    Gregor, James
    Yan, Brian
    Ponich, Terry
    Chande, Nilesh
    Mosli, Mahmoud
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2014, 49 (03) : 280 - 286
  • [2] Adalimumab in perianal Crohn's disease treatment: Experience of a tertiary center
    Carvalho, D.
    Bernardes, C.
    Russo, P.
    Saiote, J.
    Nunes, S.
    Ramos, J.
    JOURNAL OF CROHNS & COLITIS, 2015, 9 : S258 - S259
  • [3] ADALIMUMAB IN THE TREATMENT OF PERIANAL CROHN'S DISEASE: A SINGLE CENTER EXPERIENCE IN 64 PATIENTS
    Tambasco, R.
    Gionchetti, P.
    Straforini, G.
    Brugnera, R.
    Calabrese, C.
    Poggioli, G.
    Laureti, S.
    Rizzello, F.
    Campieri, M.
    DIGESTIVE AND LIVER DISEASE, 2010, 42 : S128 - S128
  • [4] Safety and efficacy of adalimumab in pediatric Crohn's disease patients
    Green, Alex
    Wyneski, Matthew
    Wyllie, Robert
    Kay, Marsha
    Mahajan, Lori
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2007, 102 : S490 - S490
  • [5] Adalimumab: the efficacy and safety in Crohn's disease
    Foster, R.
    Ambikaipaker, V.
    Radvan, G.
    Lawrence, O.
    Daley, A.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2010, 25 : A87 - A87
  • [6] EFFICACY AND SAFETY OF ADALIMUMAB IN PATIENTS WITH MODERATE TO SEVERE CROHN'S DISEASE: A SINGLE CENTRE EXPERIENCE OF OUT OF LABEL USE
    Scribano, M. L.
    Kohn, A.
    Meddi, P.
    Giglio, L. A.
    Prantera, C.
    DIGESTIVE AND LIVER DISEASE, 2008, 40 : S184 - S185
  • [7] Clinical experience with infliximab and adalimumab in a single-center cohort of patients with Crohn's disease
    Riis, Ase
    Martinsen, Tom C.
    Waldum, Helge L.
    Fossmark, Reidar
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2012, 47 (06) : 649 - 657
  • [8] THE PREVALENCE OF ASYMPTOMATIC EARLY SACROILIITIS IN CROHN'S DISEASE PATIENTS: THE SINGLE EXPERIENCE OF AN ITALIAN TERTIARY CARE CENTER
    Di Girolamo, M.
    Campomori, F.
    Spinella, A.
    Sandri, G.
    Bertani, A.
    Sartini, A.
    Gibertini, M.
    Merighi, A.
    Villa, E.
    DIGESTIVE AND LIVER DISEASE, 2018, 50 (02) : E194 - E194
  • [9] EFFICACY AND SAFETY OF INFLIXIMAB AND ADALIMUMAB IN CROHN'S DISEASE PATIENTS IN A SINGLE IBD CENTER: A RETROSPECTIVE REAL-LIFE STUDY
    Desideri, F.
    Pagnini, C.
    Menasci, F.
    Capasso, M.
    Corleto, V. D.
    Delle Fave, G.
    DIGESTIVE AND LIVER DISEASE, 2016, 48 : E199 - E200
  • [10] Efficacy and safety of infliximab and adalimumab in Crohn's disease: a single centre study
    Zorzi, F.
    Zuzzi, S.
    Onali, S.
    Calabrese, E.
    Condino, G.
    Petruzziello, C.
    Ascolani, M.
    Pallone, F.
    Biancone, L.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2012, 35 (12) : 1397 - 1407